Obese patients with uncontrolled Type 2 diabetes who were treated with an investigational endoscopic duodenal-jejunal bypass liner achieved near normalization of glycemic control in one week, as compared with a sham group.
Read More »Benefits of Continuous Glucose Monitoring Sustained after One Year
After one year of continuous glucose monitoring, HbA1c was sustained at 6.4% in patients with Type 1 diabetes who had HbA1c less than 7% at baseline. However, children and adolescents were less likely to use continuous glucose monitoring on a daily basis compared with adults.
Read More »Statins Do Not Eliminate Risk of Low HDL-Cholesterol Levels
Low levels of HDL cholesterol, even among statin-treated patients, are associated with a significantly increased risk of cardiovascular disease, particularly the risk of MI, a new study has shown.
Read More »Fat around Organs Linked to Decreased Heart Function
Researchers from Boston University School of Medicine have shown that fat collection in different body locations, such as around the heart and the aorta, and within the liver, are associated with certain decreased heart functions.
Read More »Fasting Not Required for Cholesterol Test
Patients do not need to fast before having their cholesterol tested, a major study has found.
Read More »Depression Increases Mortality for Diabetes Patients
Patients with diabetes and coexisting depression face substantially elevated mortality risks beyond cardiovascular deaths.
Read More »Food Insulin Index Predicts Insulin Demand of Mixed Meals
A food insulin index (FII) calculated by Australian researchers can predict the insulin demand evoked by mixed meals, according to a new report.
Read More »Walking Speed Predicts Cardiovascular Mortality in Older People
A new study has shown that walking speed in older people is predictive of cardiovascular mortality, with those in the slowest tertile three times more likely to suffer CV death over five years than those who walked faster.
Read More »Genetic Biomarker for Predisposition to Type 2 Diabetes Discovered
Compugen Ltd. announced the discovery and experimental confirmation of a genetic biomarker, CGEN-40001 for predisposition to Type 2 diabetes, the most common form of diabetes.
Read More »Olmesartan (Benicar®) Helps Prevent Microalbuminuria in Early Diabetes
Olmesartan reduced the risk of microalbuminuria by 23% in normoalbuminuric patients with Type 2 diabetes and at least one additional cardiovascular disease risk factor, results from a large European trial showed.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.